Issue 5, 2019

Rapid release from near-infrared polymer loaded liposomes for photothermal and chemo-combined therapy

Abstract

PEGylated liposomal doxorubicin is a polymeric antitumor drug approved clinically by the Food and Drug Administration, but it has no essentially increasing efficacy compared to free doxorubicin (DOX) because of the slow release rate. In this paper, a near-infrared polymer was designed and encapsulated in liposomes to photothermally accelerate the release of DOX. This polymer loaded liposome provides a maximum absorption that covers the ideal phototherapeutic window between 800 and 850 nm, which ensures an efficient photothermal release of DOX as a nano drug for the delivery of photothermal and chemo-combined therapy in a highly efficient cancer treatment.

Graphical abstract: Rapid release from near-infrared polymer loaded liposomes for photothermal and chemo-combined therapy

Supplementary files

Article information

Article type
Paper
Submitted
20 Sep 2018
Accepted
23 Dec 2018
First published
15 Jan 2019

New J. Chem., 2019,43, 2274-2277

Rapid release from near-infrared polymer loaded liposomes for photothermal and chemo-combined therapy

D. Li, M. Zhang, J. Yao and Z. Zhang, New J. Chem., 2019, 43, 2274 DOI: 10.1039/C8NJ04778B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements